Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331
Year: 2014
Type: article
Source: Blood
Authors: Leonard A. Mattano, Meenakshi Devidas, Alison M. Friedmann, Elizabeth A. Raetz, Mignon Loh, Patrick Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie Gastier-Foster, Nyla A. Heerema, Nina Kadan-Lottick, Yousif Matloub, David T Marshall, Linda C. Stork, Brent L. Wood, Naomi J. Winick, Stephen Hunger, William L. Carroll, Kelly Maloney
Institutions: Bronson Methodist Hospital, University of Florida, Massachusetts General Hospital, Primary Children's Hospital, Duke Medical Center, Johns Hopkins University, University of Alabama at Birmingham, Nationwide Children's Hospital, The Ohio State University, Yale University, Rainbow Babies & Children's Hospital, Medical University of South Carolina, Oregon Health & Science University, Seattle Cancer Care Alliance, The University of Texas Southwestern Medical Center, Children's Hospital Colorado, University of Colorado Anschutz, NYU Langone Health
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2587836646